Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.
G
144%
5-year Growth Rate
R
4/6
5-year Risk Analysis
O
91,21%
Outlook 12/26
W
90,09%
Margin of safety
T
31,78%
Analyst Price Target
H
UP
50-week EMA Trend
Company Info
EPS Growth 5Y
15,32%
Revenue growth 5Y
144,29%
Price growth 5Y
68,78%
Market Cap
$13,53 B
Long-Term Debt
$0,30 B
Quarterly earnings
04/30/2026
Dividend
$0,00
Dividend Yield
0,00%
Industry
Country
Website
ISIN Number
Ascendis Pharma A/S Price Chart
1M
3M
YTD
1Y
2Y
5Y
10Y
20Y
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
$290,54
31.78%
Last Update: 04/08/2026
Analysts: 16
Highest Price Target $340,81
Average Price Target $290,54
Lowest Price Target $249,66
Top growth stocks in the health care sector
| Stock | Rate of Return 5Y | Price 5Y | Div. 5Y | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|---|---|
|
Ascendis Pharma A/S
NasdaqGS:ASND
|
68,78% | 68,78% | 0,00% | 144,29% | 4/6 | 91,21% | 90,09% | 31,78% | UP |
